Advertisement

Psychiatrische Nosologie

  • M. Schmitz

Zusammenfassung

Chronische Substratbeeinträchtigungen führen zur Hirnleistungsschwäche (organisches Psychosyndrom). Häufiger als die organische Persönlichkeitsveränderung treten folgende Formen der Persönlichkeitsveränderung auf:

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Amsterdam JD (1991) Refractory depression; advances in neuropsychiatry and psychopharmacology, vol 2. Raven, New YorkGoogle Scholar
  2. Angst J (1987) Switch from depression to mania, or from mania to depression: role or psychotropic drugs. Psychopharmacol Bull 23: 66–67PubMedGoogle Scholar
  3. Ballanger JC (1988) The clinical use of carbamazepine in affective disorders. J Clin Psychiat 49 (Suppl): 13–19Google Scholar
  4. Ban TA, Hippius H (1988) Thirty years CINP. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  5. Benkert O, Hippius H (1986) Psychiatrische Pharmakotherapie. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  6. Berner P (1982) Psychiatrische Systematik. Huber, Bern Stuttgart WienGoogle Scholar
  7. Black DW, Winokur G, Nasrallah A (1987) The treatment of depression - electroconvulsive therapy versus antidepressants - a naturalistic evaluation of 1495 patients. Compr Psychiat 28: 169–182 (10)Google Scholar
  8. Byerley W F, Reimherr FW, Wood DR, Grosser BL (1988) Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression. J Clin Psychopharmacol 8: 112–115PubMedCrossRefGoogle Scholar
  9. Chan CH, Janicak PG, Davis JM et al. (1987) Response of psychotic and non psychotic depressed patients to tricyclic antidepressants. J Clin Psychiat 48: 197–200 (7)Google Scholar
  10. Checkley S (1988) Monoamines, depression and antidepressant drugs. Pharmacopsychiatry 21: 6–8PubMedCrossRefGoogle Scholar
  11. Cohen S, Khan A, Johnson S (1987) Pharmacological management of manic psychosis in an unlocked setting. J Clin Psychopharmacol 7: 261–263PubMedGoogle Scholar
  12. Ellison JM (1989) The psychotherapist’s guide to pharmacotherapy. Yearbook Med Publ, Chicago London Boca BatonGoogle Scholar
  13. Feighner JP, Boyer WF (1991) Selective serotonin re-uptake inhibitors. John Wiley & Sons, Chichester New YorkGoogle Scholar
  14. Friedmann A (1992) Leitfaden der Psychiatrie. Maudrich, Wien München BerlinGoogle Scholar
  15. Grenn AR (1988) The mechanism of action of antidepressant treatments: basic aspect. Pharmacopsychiatry 21: 3–5CrossRefGoogle Scholar
  16. Haag H, Heidorn A, Haag M, Grell W (1987) Sequence of affective polarity and lithium responses: priliminary report on Munich sample. Prog Neuropsychopharmacol Biol Psychiat 11: 205–208CrossRefGoogle Scholar
  17. Haase HJ (1982) Therapie mit Psychopharmaka und anderen psychotropen Medikamenten. Schattauer, StuttgartGoogle Scholar
  18. Jaspers K (1973) Allgemeine Psychopathologie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  19. Langer G, Heimann H (1983) Psyhopharmaka. Springer, WienGoogle Scholar
  20. Laux G (1988) Psychopharmaka - ein Leitfaden. Fischer, Stuttgart New YorkGoogle Scholar
  21. Linde OK (1988) Pharmakopsychiatrie im Wandel der Zeit. Tilia, KlingenmünsterGoogle Scholar
  22. Matussek N, Hippius H (1984) Tabulae psychiatricae et psychopharmacologicae. Aesophus, BaselGoogle Scholar
  23. Meryn S (1991) Schade, daß du schon gestorben bist. Strategien für ein persönliches Gesundheitsmanagement. Quintessenz, MünchenGoogle Scholar
  24. Muller B (1988) Psychotropics 88/89. Lundbeck, Heerlen NethGoogle Scholar
  25. Müller C (1973) Lexikon der Psychiatrie. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  26. Pare CMB (1987) Monoamine oxidase inhibitors in the treatment of affective disorders. Psychiat Ann 17: 309–335Google Scholar
  27. Paykel ES, Vanwoerkom AE (1987) Pharmacologic treatment of resistant depression. Psychiat Ann 17: 327–335Google Scholar
  28. Pöldinger W, Gander G (1979) Psychopharmaka in der Praxis. Roche, ParisGoogle Scholar
  29. Pöldinger W, Schmidlin P, Wider F (1983) Index psychopharmacorum, Huber, BernGoogle Scholar
  30. Rees I (1987) Developments in the pharmacologic treatment of affective disorders. Psychiat Ann 17: 297–300Google Scholar
  31. Saletu B (1989) Biologische Psychiatrie. Thieme, Stuttgart New YorkGoogle Scholar
  32. Scott J, Barker WA, Eccleston D (1988) The Newcastle chronic depression study: patient characteristics and factors associated with chronicity. Br J Psychiat 152: 28–33CrossRefGoogle Scholar
  33. Spector R, Rogers H, Roy D (1984) Psychiatry: common drug treatments; practical problems in medicine. Dunitz, LondonGoogle Scholar
  34. Wehr T (1987) Can antidepressants cause mania and worsen the course of affective illness. Am J Psychiat 144: 1403–1411PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • M. Schmitz

There are no affiliations available

Personalised recommendations